Site Search
Search Results
More Californians with Cancer, Other Chronic Diseases, Get Access to Game-Changing Testing
Sacramento , Calif. – Gov. Gavin Newsom signed the state budget on June 29, allowing for Medi-Cal implementation of Senate Bill 496. Starting July 1st, Medi-Cal and other state-regulated health insurance plans will cover comprehensive biomarker testing ... Testing for specific biomarkers – such as gene mutations – found in blood, tissues or other biospecimens provides crucial information that can help determine the most effective treatment for a particular patient, including precision medicine and targeted therapies. “Nearly 60% of all cancer drugs approved in the last five years require or recommend biomarker testing before use. Improving coverage for biomarker testing ...
Administration to Show Continued Commitment to Public Health with Stimulus Bill Signing
Statement of Daniel E. Smith, president, American Cancer Society Cancer Action Network (ACS CAN) WASHINGTON, D.C. -- February 17, 2009 -- “Cancer patients, survivors and their loved ones are eagerly awaiting President Obama’s ... programs will go a long way toward preserving health care coverage for more than 50 million needy Americans. A provision that defrays the cost of COBRA insurance with a 60% subsidy from the federal government for nine months will help individuals maintain affordable coverage at a time ...
Governor Signs Bill to Reduce the Illinois’ Cancer Burden
SPRINGFIELD, Ill. - The American Cancer Society Cancer Action Network (ACS CAN) is encouraged to see the Illinois legislature pass and Gov. J.B. Pritzker sign legislation to allow Illinois Medicaid recipients access to ... to cover routine costs associated with clinical trials. Gov. Pritzker and the legislature have taken an important step to ensure the viability of new cancer research in our state and to allow an additional 20% of Illinois residents to have access to these new, potentially lifesaving treatments and therapies,” said Shana Crews, government relations ...
New Jersey General Assembly Prioritizes Access to Colorectal Cancer Prevention & Early Detection Screenings
... Assembly approved legislation that seeks to remove financial barriers to lifesaving cancer screening. A-3523 passed the full Assembly by a vote of 78-0, edging New Jersey closer to requiring health insurers to cover colorectal cancer screenings recommended by United States Preventive Services Task Force and eliminating cost-sharing requirements for certain colonoscopies. In 2022, an estimated 4,260 New Jerseyans will be diagnosed with colorectal cancer, and, by year’s end, New Jersey residents can expect to lose 1,380 neighbors to the preventable disease. This legislation was erected to address colorectal cancer morbidity and mortality ...
Survivor Views Survey Informed Consent Statement
Purpose of this study: You have been invited to join the Survivor Views research study. If you join, you will receive a set of surveys. These surveys will help us better understand your thoughts and experiences as a cancer survivor. The surveys may ask questions about access to care, cost of treatment, different types of cancer treatments, pain management, and healthy living. Process: Today’s survey should take less than 10 ... detect, and treat cancer, and to improve the lives of cancer survivors. Compensation: There is no compensation for taking this survey. ACS CAN may provide items of small value to thank you for your time, such as gift cards or notebooks. Use of study findings: The survey results may ...
Wyoming Must Increase Access to Medicaid to Reduce Cancer, Save Lives and Money in the State
... 25,000 low-income, uninsured Wyoming residents. The bill passed the House last week, and the American Cancer Society Cancer Action Network (ACS CAN), advocacy affiliate of the American Cancer Society, and the Association for Clinical Oncology (ASCO), urge the Senate to follow suit and pass this lifesaving ... money when patients don’t have health insurance. When someone goes to a county hospital and gets care without insurance, taxpayers absorb the cost because they support the hospital through taxes," said Banu E. Symington, M.D., MACP, Sweetwater Regional Cancer Center, Hematology and ...
What will it take for palliative care to be mainstream?
"Palliative care suffers from an identity problem." That's the first line of an important article published in the New England Journal of Medicine (NEJM) today. In all of ACS CAN's work on the issue of palliative care, we've come to know too well that palliative care is misunderstood. Individuals often mistake palliative ... and economic perspective: Providing palliative care at early stages meets the important aims of better health and improved care, all at lower cost. It's no surprise we're seeing growing bipartisan support for two pieces of legislation introduced in Congress earlier this year that would ...
Local Cancer Survivor Traveled to Nation’s Capital to Urge Congress to Make Cancer a Top Priority
... cancer patients, survivors, and their loved ones from all 50 states and almost every congressional district united in Washington, D.C., as part of the annual American Cancer Society Cancer Action Network (ACS CAN) Leadership Summit and Lobby Day (LSLD). ACS CAN volunteers were some of the first people back in the Capitol to meet with lawmakers since the pandemic, urging Congress to take specific steps to make cancer a national ...
Congress Misses Critical Opportunity to Prioritize Cancer Prevention and Access to Care
... for Cancer Act, which are key priorities for cancer patients and their families. The following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) reacting to Congress’ inability to pass a bipartisan year-end health care package: “This week, Congress missed a tremendous ... Early Detection Program (NBCCEDP) through 2028 based on language from the bipartisan SCREENS for Cancer Act. The NBCCEDP provides free and low-cost critical breast and cervical cancer screenings, follow-up, diagnosis and treatment referral services to people who need them the most. Early ...
Understanding Biologic and Biosimilar Drugs
Biologics basics Biological drugs, commonly referred to as biologics, are a class of drugs that are produced using a living system, such as a microorganism, plant cell, or animal cell. Like all drugs, biologics are regulated by ... Biologics have been a part of medical treatment for a long time and have been used for treating cancer since the 1980s. Biologics can be used to treat cancer in a variety of ways. One way, immunotherapy, helps the body’s own immune system fight cancer cells. Other ... were introduced Biosimilars were introduced to the market in an effort to increase competition and reduce drug costs. In general, biologics cost more to develop and manufacture than small molecule drugs. They also take a longer time to bring to market (10 to 15 years versus 7 to 10 ...
Type
- Action (3) Apply Action filter
- Basic page (111) Apply Basic page filter
- Blog Post (85) Apply Blog Post filter
- Event (1) Apply Event filter
- Landing Page (1) Apply Landing Page filter
- Press Release (1181) Apply Press Release filter
- Resource (43) Apply Resource filter
- State Priority (108) Apply State Priority filter
- Update (665) Apply Update filter
Priority Issue
State
- National (243) Apply National filter
- Maine (124) Apply Maine filter
- Massachusetts (120) Apply Massachusetts filter
- New York (119) Apply New York filter
- Vermont (117) Apply Vermont filter
- New Jersey (61) Apply New Jersey filter
- Pennsylvania (51) Apply Pennsylvania filter
- Connecticut (50) Apply Connecticut filter
- Ohio (45) Apply Ohio filter
- California (44) Apply California filter
- Maryland (34) Apply Maryland filter
- North Carolina (31) Apply North Carolina filter
- Florida (30) Apply Florida filter
- Michigan (27) Apply Michigan filter
- Tennessee (26) Apply Tennessee filter
- Kentucky (25) Apply Kentucky filter
- West Virginia (25) Apply West Virginia filter
- New Mexico (24) Apply New Mexico filter
- Illinois (23) Apply Illinois filter
- South Carolina (23) Apply South Carolina filter
- Texas (23) Apply Texas filter
- Wyoming (23) Apply Wyoming filter
- Oklahoma (21) Apply Oklahoma filter
- Colorado (20) Apply Colorado filter
- Missouri (20) Apply Missouri filter
- South Dakota (20) Apply South Dakota filter
- Arizona (19) Apply Arizona filter
- Georgia (19) Apply Georgia filter
- Indiana (19) Apply Indiana filter
- Arkansas (18) Apply Arkansas filter
- Nevada (18) Apply Nevada filter
- Oregon (18) Apply Oregon filter
- New Hampshire (16) Apply New Hampshire filter
- Rhode Island (16) Apply Rhode Island filter
- Alabama (15) Apply Alabama filter
- Montana (15) Apply Montana filter
- Idaho (14) Apply Idaho filter
- Louisiana (13) Apply Louisiana filter
- Minnesota (13) Apply Minnesota filter
- North Dakota (13) Apply North Dakota filter
- Virginia (13) Apply Virginia filter
- Alaska (12) Apply Alaska filter
- Mississippi (11) Apply Mississippi filter
- Nebraska (11) Apply Nebraska filter
- Utah (11) Apply Utah filter
- Kansas (10) Apply Kansas filter
- Washington (10) Apply Washington filter
- Delaware (9) Apply Delaware filter
- District Of Columbia (9) Apply District Of Columbia filter
- Hawaii (9) Apply Hawaii filter
Policy Issue
- Access to Health Care (11) Apply Access to Health Care filter
- Prevention and Early Detection (10) Apply Prevention and Early Detection filter
- Research, Funding and Drug Development (3) Apply Research, Funding and Drug Development filter
- Health Equity (2) Apply Health Equity filter
- Patient Quality of Life (2) Apply Patient Quality of Life filter